SHARROCK DAVID B 4/A
4/A · MGI PHARMA INC · Filed Nov 6, 2003
Insider Transaction Report
Form 4/AAmended
MGI PHARMA INCMOGN
SHARROCK DAVID B
Director
Transactions
- Exercise/Conversion
Common Stock
2003-11-06$10.01/sh+5,000$50,050→ 6,000 total - Sale
Common Stock
2003-11-06$37.33/sh−300$11,199→ 3,470 total - Exercise/Conversion
Common Stock
2003-11-06$7.10/sh+1,875$13,313→ 7,875 total - Sale
Common Stock
2003-11-06$37.48/sh−1,105$41,415→ 6,570 total - Sale
Common Stock
2003-11-06$37.40/sh−1,500$56,100→ 5,070 total - Sale
Common Stock
2003-11-06$37.25/sh−270$10,058→ 1,000 total - Exercise/Conversion
Director Stock Option - Right to Buy
2003-11-06$10.01/sh−5,000$50,050→ 5,000 totalExercise: $10.01From: 2003-05-08Exp: 2011-05-08→ Common Stock (5,000 underlying) - Sale
Common Stock
2003-11-06$37.31/sh−900$33,579→ 1,570 total - Sale
Common Stock
2003-11-06$37.49/sh−200$7,498→ 7,675 total - Sale
Common Stock
2003-11-06$37.39/sh−100$3,739→ 4,970 total - Sale
Common Stock
2003-11-06$37.37/sh−1,000$37,370→ 3,970 total - Exercise/Conversion
Director Stock Option - Right to Buy
2003-11-06$7.10/sh−1,875$13,313→ 5,625 totalExercise: $7.10From: 2003-05-14Exp: 2012-05-14→ Common Stock (1,875 underlying)